SCHEMBL29622843

SCHEMBL29622843

NCCCC[C@H](N)C(=O)CCCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.63
THRB P10828 2/20 0.63
KMT2A Q03164 2/20 0.63
ALDH1A1 P00352 2/20 0.63
MEN1 O00255 1/20 0.63
PLG P00747 1/20 0.63
ALOX15 P16050 1/20 0.63
SLC6A2 P23975 1/20 0.63
RECQL P46063 1/20 0.63
SLC6A3 Q01959 1/20 0.63
NFKB1 P19838 2/20 0.59
CYP2D6 P10635 1/20 0.59
BLM P54132 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
GSR P00390 1/20 0.57
TSHR P16473 2/20 0.50
GABRR3 A8MPY1 1/20 0.50
GABRP O00591 1/20 0.50
GABRD O14764 1/20 0.50
HDAC3 O15379 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3959872 1.00 LMNA (0.63) LMNATHRBKMT2AALDH1A1MEN1
SCHEMBL29622881 1.00 LMNA (0.63) LMNATHRBKMT2AALDH1A1MEN1
SCHEMBL17029472 0.92 GSR (0.59) LMNATHRBKMT2AALDH1A1MEN1
SCHEMBL5369655 0.89 CYP2D6 (0.58) LMNATHRBKMT2AALDH1A1MEN1
Azelaic Acid SCHEMBL3338900 0.87 GSR (0.77) LMNATHRBKMT2AALDH1A1MEN1
Pimelic Acid SCHEMBL19031711 0.87 GSR (0.77) LMNATHRBKMT2AALDH1A1MEN1
Azelaic Acid SCHEMBL3338898 0.87 GSR (0.77) LMNATHRBKMT2AALDH1A1MEN1
Lysine SCHEMBL22411244 0.87 GSR (0.77) LMNATHRBKMT2AALDH1A1MEN1
Pimelic Acid SCHEMBL19031710 0.87 GSR (0.77) LMNATHRBKMT2AALDH1A1MEN1
Octanedioate SCHEMBL18496728 0.87 GSR (0.77) LMNATHRBKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4015526-B1 RECOMBINANT INTERLEUKIN-15 ANALOG LETO LABORATORIES CO LTD (CN) 2024-10-30 EP claimed
CN-112552391-B Recombinant interleukin-15 analogue 北京志道生物科技有限公司 2024-08-23 CN claimed
US-20220348624-A1 RECOMBINANT INTERLEUKIN-15 ANALOG LETO LABORATORIES CO., LTD (CN) 2022-11-03 US claimed
EP-4015526-A1 RECOMBINANT INTERLEUKIN-15 ANALOG Leto Laboratories Co., Ltd (CN) 2022-06-22 EP claimed
EP-4015526-B1 RECOMBINANT INTERLEUKIN-15 ANALOG LETO LABORATORIES CO LTD (CN) 2024-10-30 EP disclosed
CN-112552391-B Recombinant interleukin-15 analogue 北京志道生物科技有限公司 2024-08-23 CN disclosed
US-20220348624-A1 RECOMBINANT INTERLEUKIN-15 ANALOG LETO LABORATORIES CO., LTD (CN) 2022-11-03 US disclosed
EP-4015526-A1 RECOMBINANT INTERLEUKIN-15 ANALOG Leto Laboratories Co., Ltd (CN) 2022-06-22 EP disclosed